Friday Five – Lilly leaps ahead with diabetes prevention data, psychedelics’ possible path …

Weightloss News
weight loss — showed that the GIP/GLP-1 receptor agonist reduced the risk of progression to type 2 diabetes by 94% and showed sustained …